Law, criminalisation and HIV in the world: have countries that criminalise achieved more or less successful pandemic response?


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
08 2021
Historique:
received: 14 05 2021
accepted: 14 07 2021
entrez: 3 8 2021
pubmed: 4 8 2021
medline: 7 8 2021
Statut: ppublish

Résumé

How do choices in criminal law and rights protections affect disease-fighting efforts? This long-standing question facing governments around the world is acute in the context of pandemics like HIV and COVID-19. The Global AIDS Strategy of the last 5 years sought to prevent mortality and HIV transmission in part through ensuring people living with HIV (PLHIV) knew their HIV status and could suppress the HIV virus through antiretroviral treatment. This article presents a cross-national ecological analysis of the relative success of national AIDS responses under this strategy, where laws were characterised by more or less criminalisation and with varying rights protections. In countries where same-sex sexual acts were criminalised, the portion of PLHIV who knew their HIV status was 11% lower and viral suppression levels 8% lower. Sex work criminalisation was associated with 10% lower knowledge of status and 6% lower viral suppression. Drug use criminalisation was associated with 14% lower levels of both. Criminalising all three of these areas was associated with approximately 18%-24% worse outcomes. Meanwhile, national laws on non-discrimination, independent human rights institutions and gender-based violence were associated with significantly higher knowledge of HIV status and higher viral suppression among PLHIV. Since most countries did not achieve 2020 HIV goals, this ecological evidence suggests that law reform may be an important tool in speeding momentum to halt the pandemic.

Identifiants

pubmed: 34341021
pii: bmjgh-2021-006315
doi: 10.1136/bmjgh-2021-006315
pmc: PMC8330576
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Trop Med Hyg. 2020 Nov;103(5):1780-1782
pubmed: 32940202
Lancet. 2019 May 4;393(10183):1857-1910
pubmed: 31053306
AIDS Behav. 2015 Feb;19(2):227-34
pubmed: 25086670
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32938607
Lancet. 2015 Jan 17;385(9964):287-301
pubmed: 25059950
Health Policy Plan. 2013 Oct;28(7):681-91
pubmed: 23197431
Lancet HIV. 2017 Mar;4(3):e98-e99
pubmed: 28130027
Int J Drug Policy. 2015 Feb;26 Suppl 1:S27-32
pubmed: 25265900
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947
Lancet HIV. 2017 Mar;4(3):e134-e140
pubmed: 28130026
PLoS One. 2011;6(12):e28760
pubmed: 22194906
World Dev. 2020 Oct;134:105054
pubmed: 32834372
N Engl J Med. 2019 Jul 18;381(3):286-288
pubmed: 31314975
N Engl J Med. 2020 Jul 2;383(1):1-4
pubmed: 32609976
PLoS Med. 2020 Oct 23;17(10):e1003324
pubmed: 33095764
Lancet. 2012 Jul 28;380(9839):400-10
pubmed: 22819662
Lancet. 2016 Jul 9;388(10040):198-206
pubmed: 27411880
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32999052
Lancet. 2014 Dec 13;384(9960):2091-3
pubmed: 25245179
Nat Commun. 2020 Feb 18;11(1):773
pubmed: 32071298

Auteurs

Matthew M Kavanagh (MM)

Department of International Health, Georgetown University, Washington, District of Columbia, USA matthew.kavanagh@georgetown.edu.
O'Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA.

Schadrac C Agbla (SC)

Department of Health Data Science, University of Liverpool, Liverpool, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Marissa Joy (M)

O'Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA.

Kashish Aneja (K)

O'Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA.
Society for Democratic Rights, New Delhi, India.

Mara Pillinger (M)

O'Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA.

Alaina Case (A)

Talus Analytics, Boulder, Colorado, USA.

Ngozi A Erondu (NA)

O'Neill Institute for National and Global Health Law, Georgetown University, Washington, District of Columbia, USA.

Taavi Erkkola (T)

Strategic Information Department, Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneve, Switzerland.

Ellie Graeden (E)

Talus Analytics, Boulder, Colorado, USA.
Center for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH